Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
DG

DGX

Market Closed

Quest Diagnostics Incorporated

NYSEHealthcareMedical - Diagnostics & Research
US
57.00K employees
CEO: James E. Davis
Founded: 1996
$259.60
+$0.00(+NaN%)
Market Cap
28.56B
Beta
0.55
52W Range
N/A
Dividend Yield
1.30%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Quest Diagnostics trades 9% above its PERT-weighted fair value with high confidence, indicating potential overvaluation. Monte Carlo analysis reveals high volatility and downside risk (66.7%), despite an expected value near current levels. Valuation methods diverge sharply, reflecting uncertainty in growth and profit sustainability.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore DGX

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

DGX in the Healthcare

Large Cap
Healthcare

Browse sector stocks →

Medical - Diagnostics & Research

Browse industry stocks →